Showing results (691-700 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|March 8, 2022
Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic StudiesTakuya Nagashima, Takashi Hayakawa, Hayato Akimoto, et al.Clinical Pharmacology and Therapeutics|January 1, 1975
Pharmacokinetics of guanazole in patients with acute myelocytic leukemiaC Dave, D Higby, J Mattern, et al.Clinical Pharmacology and Therapeutics|November 5, 1999
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsJ D Rogers, J Zhao, L Liu, et al.Clinical Pharmacology and Therapeutics|November 5, 1999
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functionsT Hartung, W D Doecke, D Bundschuh, et al.Clinical Pharmacology and Therapeutics|February 11, 2000
In vivo effects of interleukin-10 on human cytochrome P450 activityJ C Gorski, S D Hall, P Becker, et al.Clinical Pharmacology and Therapeutics|August 25, 1999
Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of toleranceR A Mathôt, W P GeusClinical Pharmacology and Therapeutics|June 29, 2000
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcaponeK Jorga, L Banken, B Fotteler, et al.Clinical Pharmacology and Therapeutics|June 29, 2000
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphomaE Zylber-Katz, J M Gomori, A Schwartz, et al.Clinical Pharmacology and Therapeutics|June 29, 2000
Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolismN L Benowitz, P JacobClinical Pharmacology and Therapeutics|June 29, 2000
Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans studyK Erb, B Pechstein, A Schueler, et al.Pageof 941